The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

Cited by (622)

Items 401–500 of 622

1. Synergistic lethality between auranofin-induced oxidative DNA damage and ATR inhibition in cancer cells
   Zhang Shan, Yue Zhao, Xueqi Wang, Ce Qi, Jialiang Tian, Zhihua Zou · 2023 · Life Sciences
2. AI-based classification of anticancer drugs reveals nucleolar condensation as a predictor of immunogenicity
   Giulia Cerrato, Peng Liu, Liwei Zhao, Adriana Petrazzuolo, Juliette Humeau, Sophie Theresa Schmid, Mahmoud Abdellatif, Allan Sauvat, Guido Kroemer · 2024 · Molecular Cancer
3. Advances in cancer genomics and precision oncology
   Yonjong Heo, Woo‐Jin Kim, Yong‐Joon Cho, Jaewon Jung, Nam‐Soo Kim, Ik‐Young Choi · 2025 · Genes & Genomics
4. Radiation Therapy Personalization in Cancer Treatment: Strategies and Perspectives
   Marco Calvaruso, Gaia Pucci, Cristiana Alberghina, Luigi Minafra · 2025 · International Journal of Molecular Sciences
5. pH-responsive cocktail drug nanocarriers by encapsulating paclitaxel with doxorubicin modified poly(amino acid)
   Qian He, Sheng Huang, Suying Xu, Leyu Wang · 2015 · RSC Advances
6. Integrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast Cancer
   Chao Liu, Florian Rohart, Peter T. Simpson, Kum Kum Khanna, Mark A. Ragan, Kim‐Anh Lê Cao · 2016 · Scientific Reports
7. Ataxia-telangiectasia–Mutated Protein Kinase Levels Stratify Patients With Pancreatic Adenocarcinoma Into Prognostic Subgroups With Loss Being a Strong Indicator of Poor Survival
   Carsten Kamphues, Roberta Bova, Marcus Bahra, Frederick Klauschen, Alexander Muckenhuber, Bruno Valentin Sinn, Arne Warth, Benjamin Frank Goeppert, Volker Endris, P. Neuhaus et al. · 2014 · Pancreas
8. Suppression of STN1 enhances the cytotoxicity of chemotherapeutic agents in cancer cells by elevating DNA damage
   Qing Zhou, Weihang Chai · 2016 · Oncology Letters
9. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance
   Yingguang Li, Kexin Yue, Linrong Li, Jie Niu, Hanfang Liu, Jing Ma, Songqiang Xie · 2020 · Bioorganic Chemistry
10. Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine
    Zhou Tong, Cong Yan, Yuan Dong, Ming Yao, Hangyu Zhang, Lulu Liu, Yi Zheng, Peng Zhao, Yimin Wang, Weijia Jia Fang et al. · 2020 · BMC Medical Genomics
11. Clonal Evolution Dynamics in Primary and Metastatic Lesions of Pancreatic Neuroendocrine Neoplasms
    Zhou Tong, Lin Wang, Weiwei Shi, Yanwu Zeng, Hangyu Zhang, Lulu Liu, Yi Zheng, Chunlei Chen, Weiliang Xia, Weijia Jia Fang et al. · 2021 · Frontiers in Medicine
12. Pharmacogenomics and pharmacoepigenomics: Impact on therapeutic strategies
    Neetu Soni, Namrata Soni, Rahul Maheshwari, Shreya Thakkar, Dilip Sharma, Rakesh Kumar Tekade, Nagaraja Sreeharsha, Muktika Tekade · 2020 · Elsevier eBooks
13. Natural killer cell-mimicking nanomaterial for overcoming the multidrug resistance of tumor via cascade catalysis
    Min-Jie Li, Fan Gao, Qian‐Xiao Huang, Jun Feng, Chuan‐Jun Liu, S. Gong, Xian-Zheng Zhang · 2022 · Science China Materials
14. Extracellular vesicle-mediated chemoresistance in breast cancer: focus on miRNA cargo
    Maria Chiara Ciferri, Roberta Tasso · 2025 · Extracellular Vesicles and Circulating Nucleic Acids
15. FeS embedded bioreactor collaborate with artesunate for cascade-catalytic tumor ferroptosis
    Xiaoyu Wang, Chunzhe Xu, Hantao Tian, Yu Pang, Jie Lv, Meng Li · 2025 · Journal of Colloid and Interface Science
16. Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review
    Michal Chovanec, Fadi Taza, Maitri Kalra, Noah M. Hahn, Kenneth P. Nephew, Michael J. Spinella, Costantine Albany · 2017 · Targeted Oncology
17. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
    Leon Emanuel Schnöller, Valerie S. Albrecht, Nikko Brix, Alexander Edward Nieto, Daniel F. Fleischmann, Maximilian Niyazi, Julia Heß, Claus Belka, Kristian Unger, Kirsten Lauber et al. · 2022 · Radiation Oncology
18. Combined therapy with cisplatin and 5-AZA-2CdR modifies methylation and expression of DNA repair genes in oral squamous cell carcinoma.
    Dieila Giomo de Lima, Guilherme Castro Lima Silva do Amaral, Aline Cristiane Planello, Gabriell Bonifácio Borgato, Gustavo Narvaes Guimarães, Ana Paula de Souza · 2022 · PubMed Central
19. Biologie moléculaire des cancers épithéliaux de l’ovaire
    Alexandra F. Leary, Patricia Pautier, Youssef Tazi, Philippe Morice, Pierre Duvillard, Sébastien Gouy, Catherine Uzan, H. Kolesnikov Gauthier, Corinne Balleyguier, C. Lhommé · 2012 · Bulletin du Cancer
20. Effect of AR antagonist combined with PARP1 inhibitor on sporadic triple-negative breast cancer bearing AR expression and methylation-mediated BRCA1 dysfunction
    Meixiang Sang, Meng Lc, Cuicui Ma, S L Liu, Meijie Sang, Sheng Chang, Fei Liu, Yishui Lian, Cuizhi Geng · 2018 · Biomedicine & Pharmacotherapy
21. De�novo transcriptome analysis and gene expression profiling of fish scales isolated from Carassius�auratus during space flight: Impact of melatonin on gene expression in response to space radiation
    Yukihiro Furusawa, Tatsuki Yamamoto, Atsuhiko Hattori, Nobuo Suzuki, Jun Hirayama, Toshio Sekiguchi, Yoshiaki Tabuchi · 2020 · Molecular Medicine Reports
22. A DNA Repair-Based Model of Cell Survival with Important Clinical Consequences
    Anders Brahme · 2020 · Radiation Research
23. Apoptin Towards Safe and Efficient Anticancer Therapies
    Claude Backendorf, Mathieu H. M. Noteborn · 2014 · Advances in experimental medicine and biology
24. The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
    Joanna Kozłowska, Kinga Kozioł, Maciej Stasiak, Justyna Obacz, Kacper Guglas, Paulina Poter, Andrzej Adam Mackiewicz, Tomasz Kolenda · 2020 · Współczesna Onkologia
25. Nonrepair functions of DNA mismatch repair proteins: new avenues for precision oncology
    Jerry Tyler DeWitt, Megha Raghunathan, Svasti Haricharan · 2024 · Trends in cancer
26. Arginine methylation in cancer: mechanisms and therapeutic implications
    Yuanyuan Xu, Qihui Wu, Yuxiu Zhang, Yijin Gu, Hui Zhu, Xiaodan Fu, Anqi Li, Yimin Li · 2025 · Biomarker Research
27. Significant associations between X-ray repair cross-complementing group 3 genetic polymorphisms and thyroid cancer risk
    Xiaolong Yu, Hu Liu, Bin Wang, Zhengju Fu, Ying Yuan, Sheng-li Yan, Wenjuan Zhao, Yangang Wang, Jianming Cai · 2013 · Tumor Biology
28. Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
    Elli Narvi, Katri Mataleena Vaparanta, Anna Karrila, Deepankar Chakroborty, Sakari Knuutila, Arto Tapio Pulliainen, Maria Sundvall, Klaus Elenius · 2018 · Scientific Reports
29. DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients
    Min‐Yi Lv, Wei Ting Wang, Min‐Er Zhong, Du Cai, Dejun Fan, Chenghang Li, Wei-Bin Kou, Ze-Ping Huang, Xin Duan, Chuling Hu et al. · 2022 · Frontiers in Genetics
30. Cell-Cycle Control and DNA-Damage Signaling in Mammals
    Valentí Gómez, Alexander Hergovich · 2016 · Elsevier eBooks
31. A novel anti-cancer role of β-apopicropodophyllin against non-small cell lung cancer cells
    Ju Yeon Kim, Jeonghyun Cho, Jong‐Ryoo Choi, Hyun-Jin Shin, Jie‐Young Song, Sang‐Gu Hwang, Hong‐Duck Um, Young Do Yoo, Joon Kim, Jong Kuk Park · 2018 · Toxicology and Applied Pharmacology
32. Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy
    Jeunghun Lee, Yukiko Shishido‐Hara, Kaori Suzuki, Saki Shimizu, Keiichi Kobayashi, Hiroshi Kamma, Yoshiaki Shiokawa, Motoo Nagane · 2017 · Japanese Journal of Clinical Oncology
33. The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy
    Xinlan Hu, Yan Wu, Mengmeng Yao, Zhuo Chen, Qianbin Li · 2025 · Future Medicinal Chemistry
34. Delivery of Natural Small Molecules Through Nanocarriers for Cancer Treatment
    Fangting Ye, Shaojie Zheng, Shuo Shan, Jiaer Cai, Yufan Liu, Weichao Chen, Xinxin He, Chao Zhao · 2025 · Food Frontiers
35. Dormant and activated polyploid giant cancer cells: From chemoradiotherapy resistance to cancer progression
    Jiayue Liu, Kai Liu, Man Yan, Jing Xu, Yandi Liu, Shiwu Zhang · 2025 · Cancer Letters
36. Molecular chaperones in DNA repair mechanisms: Role in genomic instability and proteostasis in cancer
    Adria Hasan, Suroor Fatima Rizvi, Sana Parveen, Snober Shabnam Mir · 2022 · Life Sciences
37. Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy
    Jiyong Wu, Jing Nie, Yepeng Luan, Yanjiao Ding · 2022 · Current Medicinal Chemistry
38. miR-653-3p promotes genomic instability of colorectal cancer cells via targeting SIRT1/TWIST1 signaling pathway
    Huani Wang, Yutong Liang, Lili Zhao, Jiaqiang Deng, Yan Li, Hong Zhao, Xiao Li Zhang, Fangdong Zou · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
39. Unveiling the relationship between WWOX and BRCA1 in mammary tumorigenicity and in DNA repair pathway selection
    Tirza Bidany-Mizrahi, Aya Shweiki, Kian Maroun, Lina Abu-Tair, Bella Mali, Rami I. Aqeilan · 2024 · Cell Death Discovery
40. A telomerase-responsive nanoprobe with theranostic properties in tumor cells
    He-Hua Zhang, Li-Dong Zhao, Peng Zuo, Bin‐Cheng Yin, Bang‐Ce Ye · 2020 · Talanta
41. Analytical Challenges in Development of Chemoresistance Predictors for Precision Oncology
    Mariana Bleker de Oliveira, Vasilij Koshkin, Geoffrey Liu, Sergey N. Krylov · 2020 · Analytical Chemistry
42. Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression
    Lei Cheng, Li‐Xin Qiu, Mengyun Wang, Ruoxin Zhang, Menghong Sun, Xiaodong Zhu, Yanong Wang, Qingyi Wei · 2017 · Molecular Carcinogenesis
43. Leveraging Mathematical Modeling to Quantify Pharmacokinetic and Pharmacodynamic Pathways: Equivalent Dose Metric
    Matthew T. McKenna, Jared A. Weis, Vito Quaranta, Thomas E. Yankeelov · 2019 · Frontiers in Physiology
44. Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines
    Dong-Joon Min, Yingdong Zhao, Anne P. Monks, Alida Palmisano, Curtis D. Hose, Beverly A. Teicher, James H. Doroshow, Richard M Simon · 2019 · Cancer Chemotherapy and Pharmacology
45. Mitomycin C treatment induces resistance and enhanced migration via phosphorylated Akt in aggressive lung cancer cells
    Shen, Cheng-Ying, Chen, Li-Han, Lin, Yu-Fen, Lai, Liang-Chuan, Chuang, Eric Y., Tsai, Mong-Hsun · 2016 · Oncotarget
46. Poly(ADP-ribose) polymerase-1 (PARP1)-based dual inhibitors targeting cancer synthetic lethality (2022-present): advances and perspectives
    G.H. Ye, Yuqing Zhang, Meng-Lan He, Meng-Qian Yu, Shun-Ran Li, Bo-Qun Du, Yuan Gao, Yuan Gao, Xiang‐Yang Ye · 2025 · European Journal of Medicinal Chemistry
47. A high-throughput 384-well CometChip platform reveals a role for 3-methyladenine in the cellular response to etoposide-induced DNA damage
    Jianfeng Li, Alison Beiser, Nupur B. Dey, Shunichi Takeda, Liton Kumar Saha, Kouji Hirota, L. Lynette Parker, Mariah Carter, Martha I. Arrieta, Robert William Sobol · 2022 · NAR Genomics and Bioinformatics
48. Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
    Lianhui Sun, Guangjian Fan, Zhuqing Zhang, Dong Chang, Xiaoyu Zhang, Tongqing Zhang, Jichuan Geng, Xiaoxia Zhang, Menghan Lin, Hu Chen et al. · 2025 · Cell Reports
49. Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy
    Bingteng Xie, Aiqin Luo · 2022 · Frontiers in Cell and Developmental Biology
50. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms
    Ching‐Ying Kuo, Wen‐Cheng Chou, Chin‐Chung Wu, Teng-Song Wong, Rajesh Kakadiya, Te‐Chang Lee, Tsann‐Long Su, Hui‐Chun Wang · 2015 · Oncotarget
51. The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
    Benigno C. Valdez, Li Yang, David L. Murray, Yan Liu, Yago L. Nieto, Richard E. Champlin, Börje S. Andersson · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
52. Reevaluation of ATR signaling in primary resting chronic lymphocytic leukemia cells: evidence for pro-survival or pro-apoptotic function
    Maxime Beyaert, Eliza Starczewska, Ana Cristina Gonzalez-Perez, Nicolas Vanlangendonck, Pascale Saussoy, Gaëlle Tilman, Anne De Leener, Marie‐Christiane Vekemans, Eric Van Den Neste, Françoise Bontemps · 2017 · Oncotarget
53. ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin
    Xiao-Yan Ma, Jiafu Zhao, Yong Ruan, Wangming Zhang, Lun-Qing Zhang, Zhengdong Cai, Houqiang Xu · 2022 · Molecules
54. An engineered nanoplatform cascade to relieve extracellular acidity and enhance resistance-free chemotherapy
    Yuqing Tong, Meng Gu, Xingyu Luo, Haifeng Qi, Wei Jiang, Yu Deng, Lulu Wei, Jun Liu, Yin Ding, Jianfeng Cai et al. · 2023 · Journal of Controlled Release
55. A medicinal chemistry perspective on ATR: Current status and future directions
    Kun Li, Xiangxi Sun, Shengyu Liu, Yidong Liu, Xue Feng, Guogang Zhang · 2025 · European Journal of Medicinal Chemistry
56. Effect of mitomycin C on X‐ray repair cross complementing group 1 expression and consequent cytotoxicity regulation in human gastric cancer cells
    Shui‐Yi Tung, Chien‐Tsong Lin, Cheng‐Nan Chen, Wen‐Shih Huang · 2019 · Journal of Cellular Biochemistry
57. Cytotoxic and Apoptotic Activity of Majoranolide from Mezilaurus crassiramea on HL-60 Leukemia Cells
    Lanna M. Heemann, Kamylla Fernanda Souza de Souza, Danilo Tófoli, Kelly Juliana Filippin, Walmir Silva Garcez, Maria de Fátima Cepa Matos, Fernanda Rodrigues Garcez, Renata Trentin Perdomo · 2019 · Evidence-based Complementary and Alternative Medicine
58. High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines
    Atsuya Morita, Keisuke Aoshima, Kevin Christian Montecillo Gulay, Shinichi Onishi, Yuki Shibata, Hironobu Yasui, Atsushi Kobayashi, Takashi Kimura · 2019 · Research in Veterinary Science
59. DNA methylation‑regulated miR‑155‑5p depresses sensitivity of esophageal carcinoma cells to radiation and multiple chemotherapeutic drugs via suppression of MAP3K10
    Wenguang Luo, Huanhuan Zhang, Xue Liang, Ran Xia, Hui Deng, Qiyi Yi, Lei Lv, Liting Qian · 2020 · Oncology Reports
60. Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance
    Adalgisa Condoluci, Davide Rossi · 2021 · Journal of the National Comprehensive Cancer Network
61. Dynamic Modelling of DNA Repair Pathway at the Molecular Level: A New Perspective
    Paola Lecca, Adaoha Ihekwaba · 2022 · Frontiers in Molecular Biosciences
62. Mechanisms of multidrug resistance in cancer
    Fatemeh Zahedipour, Prashant Kesharwani, Amirhossein Sahebkar · 2023 · Elsevier eBooks
63. Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1
    Dimitri Topalis, Tatiane Cristina de Araujo Nogueira, Tim De Schutter, Chahrazade El Amri, Marcela Krečmerová, Lieve M. J. Naesens, Jan M. Balzarini, Graciela Andreï, Robert Snoeck · 2016 · Oncotarget
64. Perturbed Signaling and Role of Posttranslational Modifications in Cancer Drug Resistance
    Suruchi Aggarwal, Manu Kandpal, Shailendra Asthana, Amit Kumar Yadav · 2017 · Springer eBooks
65. Altered expression of telomere‐associated genes in leukocytes among BRCA1 and BRCA2 carriers
    Hiromi Tanaka, Elizabeth A. Phipps, Ting Wei, Xi Wu, Chirayu Pankaj Goswami, Yunlong Liu, George W. Sledge, Lida A. Mina, Brittney‐Shea Herbert · 2017 · Molecular Carcinogenesis
66. Hoxa5 inhibits adipocyte proliferation through transcriptional regulation of Ccne1 and blocking JAK2/STAT3 signaling pathway in mice
    Miao Pan, Qian Sun, Chaowei Li, Ruiqing Tai, Xin’e Shi, Chao Sun · 2022 · Biochemistry and Cell Biology
67. Inhibition of insulin‐like growth factor‐1 receptor enhances eribulin‐induced DNA damage in colorectal cancer
    Tomoyasu Yoshihiro, Hiroshi Ariyama, Toshihiro Yamaguchi, Takashi Imajima, Satoru Yamaga, Kenji Tsuchihashi, Taichi Isobe, Hitoshi Kusaba, Koichi Akashi, Eishi Baba · 2022 · Cancer Science
68. Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance
    Forough Alemi, Yadollah Poornajaf, Foroogh Hosseini, Vahid Vahedian, Mahdi Gharekhani, Hamed Shoorei, Mohammad Naser Taheri · 2024 · Molecular Biology Reports
69. Expression quantitative trait loci influence DNA damage-induced apoptosis in cancer
    Jessica Bigge, Laura L. Koebbe, Ann-Sophie Giel, Dorothea Bornholdt, Benedikt C. Buerfent, Pouria Dasmeh, Alexander M. Zink, Carlo Maj, J H Schumacher · 2024 · BMC Genomics
70. A first glance on the enhancement of digital cell activity videos from glioblastoma cells with nuclear staining
    Saul Calderon, Daniel Moya, Juan C. Cruz, Juan Manuel Valverde · 2016 · IEEE Central America and Panama Convention (CONCAPAN)
71. 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties
    Lukáš Górecki, Darina Muthná, Sara Merdita, Martin Andrš, Tomas Kucera, Radim Havelek, Ľubica Múčková, Tereza Kobrlová, Jiri Soukup, Petr Krůpa et al. · 2022 · European Journal of Medicinal Chemistry
72. Elucidation of Increased Cervical Cancer Risk Due to Polymorphisms in XRCC1 (R399Q and R194W), ERCC5 (D1104H), and NQO1 (P187S)
    Agneesh Pratim Das, Sandeep Saini, Shrishty Tyagi, Nisha Chaudhary, Subhash Mohan Agarwal · 2022 · Reproductive Sciences
73. POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1
    Ge Liu, Kaifeng Jin, Zhaopei Liu, Xiaohe Su, Ziyue Xu, Bingyu Li, Jingtong Xu, Yuan Chang, Yiwei Wang, Yu Zhu et al. · 2024 · Cancer Medicine
74. Synthesis and biological evaluation of novel N-substituted benzamides as anti-migration agents for treatment of osteosarcoma
    Xiaojing Chen, Guangbao Wang, Ali Mohammed Mohammed Alsayed, Zongxuan Du, Lu Liu, Yue Ma, Peng Liu, Qianwen Zhang, Xianxin Chen, Wenbin Chen et al. · 2021 · European Journal of Medicinal Chemistry
75. Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer
    Adlina Roslan, Nurshahira Sulaiman, Khairul Asri Mohd Ghani, Armania Nurdin · 2022 · Pharmaceutics
76. A Preliminary Study of NER and MMR Pathways Involved in Chemotherapy Response in Bladder Transitional Cell Carcinoma: Impact on progression-free survival.
    Vahideh Montazeri, Mohammad Hossein Ghahremani, Hamed Montazeri, Mandana Hasanzad, Dornaz Safavi, Mohsen Ayati, Mohammad Chehrazi, Baharak Arefi Moghaddam, Seyed Nasser Ostad · 2020 · PubMed Central
77. Induction of moderate DNA damage enhances megakaryopoiesis and platelet production
    Roelof Hendrik Bekendam, Virginia Camacho, Andrew P. Stone, María N. Barrachina, Siobhan Laken Branfield, Estelle Carminita, Isabelle C. Becker, Dong Hoon Lee, Ethan Walsey, Clementine Payne et al. · 2025 · Blood Advances
78. Light Activated Induction of Cuproptosis in Resistant Cancer Cells Using Polymeric BODIPY Nanoparticles for Photoactivated Chemotherapy
    Ricarda Zimmermann, Nicolás Montesdeoca, Johannes Karges · 2026 · Advanced Functional Materials
79. Ursolic acid-piperazine-dithiocarbamate ruthenium(II) polypyridyl complexes induced necroptosis in MGC-803 cells
    Hong Jiang, Jian-Hua Wei, Cuiyan Lin, Gui-Bin Liang, Rui-Jie He, Ri-Zhen Huang, Xian‐Li Ma, Guobao Huang, Ye Zhang · 2022 · Metallomics
80. Combining Immune-Related Genes For Delineating the Extracellular Matrix and Predicting Hormone Therapy and Neoadjuvant Chemotherapy Benefits In Breast Cancer
    Jianyu Liu, Bo Lei, Xin Yu, Yingpu Li, Yuhan Deng, Guang Yang, Zhigao Li, Tong Liu, Leiguang Ye · 2022 · Frontiers in Immunology
81. The DNA Damage Response Mediates Apoptosis and Tumor Suppression
    Katherine Baran, Diego A. Rodríguez, Douglas R. Green · 2013 · Springer eBooks
82. RETRACTED: Liposomal valinomycin mediated cellular K+ leak promoting apoptosis of liver cancer cells
    Qianwen Zhang, Mirza Muhammad Faran Ashraf Baig, Tian-Qi Zhang, Ting-Ting Zhai, Xiang Qin, Xing‐Hua Xia · 2021 · Journal of Controlled Release · Retracted
83. STING Promotes Breast Cancer Cell Survival by an Inflammatory-Independent Nuclear Pathway Enhancing the DNA Damage Response
    Laura Cheradame, Ida Chiara Guerrera, Julie Gaston, Alain Schmitt, Vincent A. Jung, Marion Pouillard, Nina Radosevic‐Robin, Mauro Modesti, Jean‐Gabriel Judde, Stefano Cairo et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
84. Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer
    Yongtao Li, Zhicheng Zhou, Yiqun Zhang, Deyong Jia, Ding Wang, Mary C. Reiger, Chad J. Creighton, Peter S. Nelson, Eva Corey, Colm M. Morrissey et al. · 2025 · Oncogene
85. Useful genes for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma
    Yuan Guo, Hongtao Hu, Shi‐Jun Xu, Weili Xia, Hai-Liang Li · 2022 · Journal of Cancer Research and Therapeutics
86. Tubule-specific cyclin-dependent kinase 12 knockdown potentiates kidney injury through transcriptional elongation defects
    Yilin Zhang, Tao‐Tao Tang, Wei‐Jie Ni, Zhong-Tang Li, Liang-Yun-Zi Jiang, Yao Wang, Xuan Zhou, Jing-Yuan Cao, Qing Yin, Wei Jiang et al. · 2024 · International Journal of Biological Sciences
87. A mathematical model to study low-dose metronomic scheduling for chemotherapy
    Garhima Arora, Nandadulal Bairagi, Samrat Chatterjee · 2024 · Mathematical Biosciences
88. BRAF V600E-induced distinct DNA damage response defines the therapeutic potential of p53 activation for TP53 wild-type colorectal cancer
    Shinji Tokuyama, Hisakazu Kato, Hidekazu Takahashi, Kyoko Ueda, Asami Arita, Ryuta Ueda, Hiroto Seto, Yuki Sekido, Tsuyoshi Hata, Atsushi Hamabe et al. · 2024 · Carcinogenesis
89. Interplay Between the Cytoskeleton and DNA Damage Response in Cancer Progression
    Clarissa Esmeralda Halim, Shuo Deng, Karen Crasta, Celestial T. Yap · 2025 · Cancers
90. Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
    Mateusz Rytelewski, Adrian V. Buensuceso, Hon Sing Leong, Bonnie J. Deroo, Ann F. Chambers, James D. Koropatnick · 2015 · Journal of Visualized Experiments
91. Roles of GST-π and polβ Genes in Chemoresistance of Esophageal Carcinoma Cells
    Yue Tang, Xiaoyan Xuan, Min Li, Ziming Dong · 2013 · Asian Pacific Journal of Cancer Prevention
92. Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?
    Narjust Duma, Kelly C. Gast, Grace Mei Yee Choong, Roberto Antonio Leon-Ferre, Ciara Catherine O'Sullivan · 2018 · Current Oncology Reports
93. Natural product–based nanomedicine: polymeric nanoparticles as delivery cargoes of food bioactives and nutraceuticals for anticancer purposes
    Francine Carla Cadoná, Alencar Kolinski Machado, David Frederick Bodenstein, Carina Rossoni, Fernanda Reis Favarin, Aline Ferreira Ourique · 2020 · Elsevier eBooks
94. The suppressive role of GLS in radiosensitivity and irradiation-induced immune response in LUAD: integrating bioinformatics and experimental insights
    Peicheng Jiang, Zhifeng Jiang, Li Su, Ye‐Xiong Li, Yuqiong Chen, Xinyan Li · 2025 · Frontiers in Immunology
95. The Prognostic Value of the XPC rs2228001 Single Nucleotide Polymorphism in Cholangiocarcinoma
    Guanwu Wang, Anna Mantas, Dong Liu, Tarick M. Al‐Masri, Smiths Lueong, Jens Thomas Siveke, Tom Luedde, Tom Florian Ulmer, Iakovos Amygdalos, Florian W. R. Vondran et al. · 2025 · Liver International
96. Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patients
    Ali T. Arafa, Ella Boytim, Megan Ludwig, Lily Kollitz, Tianzhong Yang, Kathleen M. Storey, Stuart H. Bloom, Gautam Jha, Ian J. Okazaki, Charles J. Ryan et al. · 2026 · Cell Reports Medicine
97. Overexpression of H2AFX gene in neuroblastoma is associated with worse prognosis
    Marzia Ognibene, Stefano Parodi, Loredana Amoroso, Federico Zara, Annalisa Pezzolo · 2024 · Pediatric Blood & Cancer
98. Transport of DNA repair proteins to the cell nucleus by the classical nuclear importin pathway – a structural overview
    Marcos R.M. Fontes, Fábio Florença Cardoso, Boštjan Kobe · 2025 · DNA repair
99. Untitled work
    2013 · Digital Commons - East Tennessee State University (East Tennessee State University)
100. Cell cycle control and DNA-damage signaling in mammals
     Ramazan Gündoğdu, Alexander Hergovich, Valentí Gómez · 2021 · Elsevier eBooks